Alnylam Pharmaceuticals, Inc. (ALNY)

329.31 -3.61 (-1.08%) USD  |  NASDAQ  |  Mar 02, 14:42
More

Alnylam Pharmaceuticals Total Equity Including Minority Interest (Quarterly)

Total Equity Including Minority Interest (Quarterly) Chart

View Total Equity Including Minority Interest (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Equity Including Minority Interest (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years

View Total Equity Including Minority Interest (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Equity Including Minority Interest (Quarterly) Benchmarks

View Total Equity Including Minority Interest (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Biogen, Inc. Upgrade
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade